Formula E and Google Cloud are joining forces to accelerate innovation in motorsport by developing cutting-edge AI tools for ...

Vertex's cloud growth momentum remains strong, with a 27% y/y increase in 4Q24. Read more to see why I upgrade VERX stock ...

New advanced AI technology has been developed to bridge the data access gap for up and coming drivers ...

What is happening today in Washington is a travesty. And the only ones who can prevent it from going further are the people ...

Vertex Pharmaceuticals is flexing its innovation muscles beyond its cystic fibrosis stronghold, charging into new territories ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer discusses. In a recent appearance on CNBC’s ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Formula milk is the only safe alternative to breastfeeding or using breast milk for feeding your baby. If you choose not to breastfeed or are unable to, formula will help to provide the important ...